Diversity and inclusion are important pillars of the healthcare industry, especially within the clinical research space. To ensure the best overall patient care, it is critical to have an appropriate representation of the populations being researched. Understanding why and how minority populations are underrepresented allows pharmaceutical sponsors and CROs to outline actionable steps to create more diverse and equitable trials.